U.S. Pharma Stock News

ServiceNow (NYSE:NOW) has launched new AI driven platforms, Autonomous Workforce and EmployeeWorks, targeting government and healthcare clients. The company is integrating capabilities from its Moveworks acquisition and new partnership with Autonomize AI into these offerings. Forrester recently recognized ServiceNow as a leader in public sector cloud solutions, underscoring its push into regulated markets. ServiceNow enters this phase of product expansion with a mixed performance profile...

Oceaneering International (NYSE:OII) senior vice president Earl Childress recently sold a significant portion of his company stock. The insider transaction involved a sizable stake held by a top executive, drawing attention to management’s current stance on the shares. The sale has not been widely discussed yet and may influence how some investors view the near term outlook for the company. Oceaneering International, trading at around $34.44, has seen strong share price momentum, with the...

On February 23, 2026, Chewy appointed Christopher S. Deppe as its new Chief Financial Officer and principal financial officer, replacing interim appointee William Billings. Deppe’s long tenure in senior finance roles at Amazon and his recent leadership across Chewy’s corporate and commercial finance functions highlight an emphasis on cost discipline and operational depth in the finance seat. Next, we’ll examine how installing a CFO with deep Amazon logistics and cost-optimization experience...

Gap Inc. has reported its fourth-quarter and full-year 2025 results, showing slightly higher sales year over year but lower net income, while also issuing 2026 guidance calling for modest net sales growth of 1%–2% in the first quarter and 2%–3% for the full fiscal year. Alongside these results, Gap’s Board approved a 6% dividend increase, authorized a new US$1.00 billion share repurchase program after completing a prior US$750.56 million buyback, and highlighted its eighth consecutive...

WEX (WEX) recently reported quarterly results that included 5.7% year on year revenue growth, a revenue beat versus analyst expectations, and the largest full year guidance raise among its diversified financial services peers. See our latest analysis for WEX. The recent guidance raise and revenue beat appear to have coincided with improving sentiment, with a 15.1% 1 month share price return and a 9.8% 7 day share price return, even though the 5 year total shareholder return of 23.9% shows a...

Duolingo (NasdaqGS:DUOL) is shifting its focus toward long term user growth, higher AI investment and expanding beyond languages into subjects like music and math. Management has lowered guidance for near term bookings and profitability as part of this reset, contributing to recent share price volatility. The company has also announced a $400m share repurchase program alongside these changes. For investors watching NasdaqGS:DUOL, the timing of this pivot comes after a tough period for the...

Coca-Cola (NYSE:KO) has announced that Henrique Braun will become the new CEO. Current CEO James Quincey will move into the role of Executive Chairman. The leadership transition marks a significant change at the top of one of the world's largest beverage companies. Coca-Cola, listed on the NYSE under ticker KO, is a global beverage company with a portfolio that spans soft drinks, juices, water, sports drinks, coffee and tea. The CEO transition arrives as large consumer brands continue to...

In early March 2026, Silicon Motion Technology Corporation announced it had begun shipping its AI-optimized Ferri boot storage solutions and would showcase these alongside its MonTitan PCIe Gen5 enterprise SSD controllers at Embedded World 2026 in Nuremberg, targeting industrial, automotive, and AI data center applications. A distinctive aspect of this announcement is the combination of automotive-grade certifications and production shipments to leading AI ecosystem players, positioning...

If you are wondering whether Block is starting to look like value again, or if recent optimism has already been priced in, this article is for you. The stock recently closed at US$67.38, with returns of 23.6% over 7 days, 18.6% over 30 days, 3.4% year to date, 12.7% over 1 year, and longer-term returns of an 8.7% decline over 3 years and a 72.1% decline over 5 years. Recent headlines around Block have focused on its positioning within digital payments, its mix of merchant services and...

Recently, Neo Financial and United Airlines announced a partnership to launch the United MileagePlus Neo World Elite Mastercard in Canada, offering travel perks such as priority boarding, a free checked bag and extra miles on United and Star Alliance flights starting in April 2026. At the same time, United is facing operational and cost pressures from rising jet fuel prices and conflict-driven flight disruptions, creating a complex backdrop for its expansion plans and new loyalty...

What recent performance says about Kimberly-Clark Kimberly-Clark (KMB) has drawn investor attention after a mixed run in its shares, with a small 1-day gain, a decline over the past week, and positive moves over the past month and past 3 months. That recent pattern, alongside a last close near US$104.91 and a value score of 4, is prompting closer scrutiny of how its personal care and tissue brands may relate to earnings power and long-term total returns. See our latest analysis for...

If you are wondering whether CVS Health's current share price gives you a fair deal, you are not alone. This article will walk through what that price might imply about value. Over the past year, CVS Health has returned 25.2%, compared with a 2.4% move over the last 30 days and a 0.9% change in the past week, while year to date the stock shows a 1.8% decline from its last close of US$78.69. Recent headlines have focused on CVS Health's role in the broader US healthcare and pharmacy space,...

Major shareholders Warburg Pincus LLC and GTCR LLC launched a secondary offering of 25,000,000 shares of Sotera Health (NasdaqGS:SHC). The offering consists solely of shares held by these existing investors, with Sotera Health not issuing new shares or receiving proceeds. The transaction focuses on ownership changes and liquidity for current holders rather than new capital for the company. Sotera Health, a provider of sterilization and lab testing services to the healthcare and life...

SM Energy (NYSE:SM) has launched and priced US$1b in senior notes. The company plans to use the proceeds to fund a US$750m tender offer for its 2028 notes and to further optimize its debt profile. The transaction follows the recent merger with Civitas Resources and is part of post deal balance sheet repositioning. SM Energy is an independent oil and gas producer, and the Civitas merger has quickly shifted attention from deal terms to balance sheet structure. By issuing new senior notes and...

In the past quarter, Corpay, Inc. reported stronger-than-expected fourth-quarter 2025 results, with earnings per share rising 12.7% year over year and highlighting momentum across its payment solutions. Recent acquisitions of Alpha Group International, GPS Capital Markets, and Paymerang have broadened Corpay’s product suite and customer reach, underscoring how M&A is reshaping its payments platform. We’ll now examine how Corpay’s better-than-expected earnings and recent acquisitions...

Kiniksa Pharmaceuticals International (KNSA) is back in focus after reporting fourth quarter and full year 2025 results, showing higher revenue and a shift to profitability that has drawn fresh attention from traders. See our latest analysis for Kiniksa Pharmaceuticals International. The earnings release on 24 February, followed by plans to present at the TD Cowen Health Care Conference and a recent ESOP related shelf filing, comes after a strong run, with a 90 day share price return of...

If you are wondering whether Somnigroup International is still worth the current price, this article will walk you through what that market tag might really mean for long term investors. The share price closed at US$82.52, with a 9.4% decline over the last 7 days and an 11.1% decline over the last 30 days, while the 1 year return sits at 41.9% and the 3 year and 5 year returns are 110.9% and 134.5% respectively. These moves sit against a backdrop of ongoing coverage around Somnigroup...

Why ORIC Pharmaceuticals Just Drew Fresh Attention ORIC Pharmaceuticals (ORIC) is back on investor radar after releasing fourth quarter and full year 2025 results, alongside a new shelf registration that could allow the company to raise up to roughly US$35.1 million in common stock. See our latest analysis for ORIC Pharmaceuticals. ORIC Pharmaceuticals shares have been on a strong run, with a 69.52% year to date share price return and a 76.43% total shareholder return over the past year. The...

If you are wondering whether GLOBALFOUNDRIES’ share price around US$48.33 still reflects fair value, you are not alone. This article is here to unpack that question in a clear way. The stock has returned 3.0% over the last 7 days, 18.8% over the past 30 days, 31.1% year to date, and 25.9% over the last year, while its 3 year return stands at a 27.2% decline. These moves have played out against a backdrop of ongoing interest in semiconductor manufacturing capacity and supply chains, with...

Heightened tensions around Iran and the Strait of Hormuz have pushed Battalion Oil (BATL) into the spotlight, as investors gravitate toward U.S. onshore producers and react to the company’s recent $15 million private placement. See our latest analysis for Battalion Oil. The latest moves come on top of a very large recent rally, with the 7 day share price return above 3x and the year to date share price return also extremely strong, while the 1 year total shareholder return has more than...

LSB Industries, Inc. reported past fourth-quarter and full-year 2025 results showing sales of US$165.05 million and US$615.21 million respectively, alongside a shift from net losses to net income and positive earnings per share from continuing operations. The company also issued detailed 2026 production and sales guidance for key nitrogen products and completed a US$26.22 million share repurchase program, signaling management’s confidence in its operating outlook and capital allocation...

Regeneron Pharmaceuticals overview Regeneron Pharmaceuticals (REGN) has drawn investor attention after its shares closed at US$764.93, with recent returns mixed across different time frames and a long term track record that some investors continue to monitor closely. See our latest analysis for Regeneron Pharmaceuticals. Recent trading has been a bit choppy, with a 1 day share price return showing a 2.87% decline and a 90 day share price return of 6.48%, while the 1 year total shareholder...

Dynatrace (DT) is back in focus after Executive Vice President Stephen McMahon bought 3,000 company shares, a move that coincides with growing attention on its artificial intelligence driven observability platform. See our latest analysis for Dynatrace. The insider purchase comes as Dynatrace’s share price has climbed to US$39.21, with a 1 month share price return of 13.42% and a 7 day gain of 7.87%, although the 1 year total shareholder return of 26.82% decline and 5 year total shareholder...

In February 2026, EPAM Systems reported strong Q4 2025 results with double-digit revenue growth and rapidly expanding AI-native services, even as management issued cautious 2026 sales guidance and disclosed a revenue drop from the largest customer of its NEORIS business. This combination of robust operational performance, rising AI-related revenues and awards from partners like Microsoft and AWS, alongside conservative outlook and a new shareholder legal investigation, has sharpened debate...